Published in Hepatitis Weekly, June 27th, 2005
The results were presented at the American Society of Gene Therapy, in St. Louis, Missouri.
"DNA vaccines represent a bold new way to immunize humans against infectious diseases," said company president, Clague Hodgson, "However, their effectiveness up to the present has been borderline, and the science requires quantum forward leaps in both efficacy and production in order to reach practicality."
NTC scientists Jim Williams and Aaron Carnes headed up the studies at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly